HM
HealthCor Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-958,600
| Closed | -$37.1M | – | 32 |
|
|
2022
Q3 | $37.1M | Sell |
958,600
-849,390
| -47% | -$32.9M | 4.64% | 4 |
|
|
2022
Q2 | $67.4M | Sell |
1,807,990
-42,460
| -2% | -$1.58M | 6.77% | 3 |
|
|
2022
Q1 | $82M | Buy |
1,850,450
+586,780
| +46% | +$26M | 5.47% | 2 |
|
|
2021
Q4 | $53.7M | Sell |
1,263,670
-444,011
| -26% | -$18.9M | 2.92% | 11 |
|
|
2021
Q3 | $74.1M | Buy |
1,707,681
+497,111
| +41% | +$21.6M | 3.2% | 10 |
|
|
2021
Q2 | $51.8M | Buy |
1,210,570
+35,750
| +3% | +$1.53M | 2.07% | 18 |
|
|
2021
Q1 | $45.4M | Buy |
+1,174,820
| New | +$45.4M | 1.61% | 23 |
|
|
2019
Q4 | – | Sell |
-961,820
| Closed | -$39.1M | – | 57 |
|
|
2019
Q3 | $39.1M | Sell |
961,820
-509,550
| -35% | -$20.7M | 1.48% | 30 |
|
|
2019
Q2 | $63.2M | Buy |
1,471,370
+174,410
| +13% | +$7.5M | 2.45% | 14 |
|
|
2019
Q1 | $49.8M | Sell |
1,296,960
-497,650
| -28% | -$19.1M | 2.01% | 20 |
|
|
2018
Q4 | $63.4M | Buy |
1,794,610
+391,660
| +28% | +$13.8M | 1.98% | 19 |
|
|
2018
Q3 | $54M | Buy |
1,402,950
+695,090
| +98% | +$26.8M | 1.79% | 25 |
|
|
2018
Q2 | $23.1M | Buy |
707,860
+134,380
| +23% | +$4.39M | 0.74% | 34 |
|
|
2018
Q1 | $15.7M | Buy |
573,480
+205,648
| +56% | +$5.62M | 0.53% | 40 |
|
|
2017
Q4 | $9.12M | Sell |
367,832
-319,338
| -46% | -$7.92M | 0.3% | 34 |
|
|
2017
Q3 | $20M | Buy |
687,170
+233,220
| +51% | +$6.8M | 0.67% | 30 |
|
|
2017
Q2 | $12.6M | Buy |
+453,950
| New | +$12.6M | 0.45% | 32 |
|
|
2015
Q2 | – | Sell |
-2,386,700
| Closed | -$42.4M | – | 53 |
|
|
2015
Q1 | $42.4M | Sell |
2,386,700
-1,074,500
| -31% | -$19.1M | 2.02% | 14 |
|
|
2014
Q4 | $45.9M | Buy |
+3,461,200
| New | +$45.9M | 2.56% | 15 |
|